FDA Outlines Guidance for Generic Abuse-Deterrent Opioid Pills

Generic Line
A A
The FDA finalized guidance for manufacturers looking to produce generic versions of opioid painkillers with abuse-deterrent labeling, as a part of the agency’s push to lower overall exposure to opioids and prevent new addictions.

To View This Article:

Login

Subscribe To Generic Line